What is Huntington's Forecast for XRN FY2026 Earnings?

Key Points

• Huntington forecasts FY2026 earnings of $2.93 per share, above the cited consensus estimate of $2.66, and maintains a Hold rating on Global Medical REIT.
• Huntington estimates EPS of $2.28 for FY2027 and $2.67 for FY2028, with quarterly forecasts rising from $0.51 in Q4 2026 to $0.68 in Q3 2028.
• Global Medical REIT reported quarterly EPS of negative $0.67, missing the $0.55 consensus estimate; quarterly revenue was $40.34 million.

Global Medical REIT Inc. (NYSE:XRN - Free Report) - Stock analysts at Huntington issued their FY2026 earnings estimates for Global Medical REIT in a report issued on Wednesday, November 4th. Huntington analyst R. Stevenson anticipates that the company will post earnings per share of $2.93 for the year. Huntington currently has a "Hold" rating on the stock. The consensus estimate for Global Medical REIT's current full-year earnings is $2.66 per share. Huntington also issued estimates for Global Medical REIT's Q4 2026 earnings at $0.51 EPS, Q1 2027 earnings at $0.52 EPS, Q2 2027 earnings at $0.56 EPS, Q3 2027 earnings at $0.59 EPS, Q4 2027 earnings at $0.62 EPS, FY2027 earnings at $2.28 EPS, Q1 2028 earnings at $0.63 EPS, Q2 2028 earnings at $0.66 EPS, Q3 2028 earnings at $0.68 EPS and FY2028 earnings at $2.67 EPS.

Global Medical REIT (NYSE:XRN - Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported ($0.67) EPS for the quarter, missing the consensus estimate of $0.55 by ($1.22). Global Medical REIT had a return on equity of 13.35% and a net margin of 36.80%. The business had revenue of $40.34 million for the quarter.

A number of other analysts have also commented on the company. Cantor Fitzgerald initiated coverage on Global Medical REIT in a report on Monday, September 21st. They set an "overweight" rating and a $43.00 price objective for the company. Zacks Research upgraded Global Medical REIT to a "hold" rating in a report on Wednesday, July 22nd. Citizens Jmp dropped their target price on Global Medical REIT from $42.00 to $35.00 and set a "market outperform" rating on the stock in a report on Wednesday. Weiss Ratings cut Global Medical REIT from a "hold (c)" rating to a "hold (c-)" rating in a research report on Monday. Finally, Wall Street Zen downgraded Global Medical REIT from a "hold" rating to a "sell" rating in a report on Saturday, October 10th. Two investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $38.60.

Global Medical REIT Price Performance

Shares of NYSE XRN opened at $26.49 on Friday. Global Medical REIT has a fifty-two week low of $26.19 and a fifty-two week high of $38.65. The stock has a market cap of $350.95 million, a price-to-earnings ratio of 7.55 and a beta of 1.10. The company has a debt-to-equity ratio of 1.44, a quick ratio of 0.59 and a current ratio of 0.70. The firm's 50-day simple moving average is $32.78 and its 200 day simple moving average is $35.13.

Global Medical REIT Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, November 20th will be given a dividend of $0.16 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 7.2%. The ex-dividend date of this dividend is Friday, November 20th. Global Medical REIT's dividend payout ratio (DPR) is presently 54.86%.

Key Headlines Impacting Global Medical REIT

These are some of the XRN headlines that stood out recently:

• Positive Sentiment: Citizens JMP’s $35 target remains above the cited $26.49 share price, and the firm kept its market-outperform rating. Citizens JMP ratings
• Neutral Sentiment: Huntington’s forecasts call for $2.93 per share in FY2026, $2.28 in FY2027, and $2.67 in FY2028. The analyst also expects quarterly estimates to rise from $0.51 in Q4 2026 to $0.68 in Q3 2028, but maintained a Hold rating. These projections are not presented as a change to prior estimates. Global Medical REIT analyst estimates
• Negative Sentiment: Citizens JMP cut its price target from $42 to $35, a substantial reduction that may weigh on sentiment despite the retained outperform rating. Citizens JMP ratings

About Global Medical REIT

Global Medical REIT, Inc. is a healthcare-focused real estate investment trust that acquires and owns purpose-built medical facilities. It leases these properties to healthcare providers, including physician groups and health systems, that use them to deliver patient care. The company's properties include medical office buildings, specialty hospitals, ambulatory surgery centers and inpatient rehabilitation facilities. Its leases are generally structured to provide long-term occupancy for tenants while supporting the company's rental-income business.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.